 |
|
 |
Vaccine Policy and Licensing |
|
IAC has created a one-stop spot for official and authoritative information about vaccines, with Vaccine Policy and Licensing. Recommendations, policy statements,
package inserts, product approvals, publications, and position statements are indexed by date
and vaccine. Additional links are provided for CDC's Advisory Committee on Immunization Practices, Food and Drug Administration, and the World Health Organization. |
|
|
|
|
|
Advisory Committee
on Immunization Practices (ACIP) recommendations are official federal
guidelines for the use of vaccines and immune globulins in the United
States and are published by the Centers for Disease Control and Prevention
(CDC). Links to additional ACIP-related material are also provided. |
 |
|
|
|
|
|
|
The mission of the
FDA's Center for Biologics Evaluation and Research (CBER) is to protect
and enhance the public health through the regulation of biological and
related products including vaccines, blood, allergenics, tissues, and
cellular and gene therapies. In this section, package inserts and
additional FDA information for vaccines and biologics licensed for use in
the United States are provided.
Additional FDA vaccine-related resources are also listed. |
 |
|
|
|
|
|
|
In accordance with
its mandate to provide guidance to Member States on health policy matters,
the World Health Organization (WHO) publishes a series of regularly
updated position papers on vaccines that have an international public
health impact. The position papers summarize essential background
information on the respective diseases and vaccines, and conclude with the
current WHO position concerning their use in the global context. Links to
immunization-related WHO websites, resources and publications are provided. |
 |
|
|
This page was updated on November 1, 2022. |
|
This page was reviewed on November 1, 2022. |
|
 |
|